Bovine Vena Caval Thrombosis Secondary to Pneumonia – NAVLE Study Guide

Overview and Clinical Importance

Caudal vena caval thrombosis (CVCT), also known as vena caval syndrome, metastatic pneumonia, or pulmonary thromboembolism, is a severe and often fatal disease complex in cattle. It results from septic thrombi forming in the caudal vena cava, most commonly secondary to liver abscessation. The subsequent embolic showering of the pulmonary vasculature leads to embolic pneumonia, pulmonary arterial aneurysm formation, and potentially fatal pulmonary hemorrhage. This condition is of particular importance in feedlot cattle on high-grain diets and adult dairy cattle, representing a significant cause of sudden death and chronic respiratory disease in these populations.

Understanding the pathophysiology connecting ruminal acidosis, liver abscessation, vena caval thrombosis, and metastatic pneumonia is essential for NAVLE success, as this condition exemplifies the interconnection between digestive and respiratory pathology in ruminants.

Etiology and Pathogenesis

The pathogenesis of CVCT follows a well-characterized sequence known as the acidosis-rumenitis-liver abscess complex. Understanding this cascade is critical for both prevention and recognition of this disease.

The Pathogenic Cascade

Step 1: Ruminal Acidosis

Subacute ruminal acidosis (SARA) occurs when cattle consume diets high in readily fermentable carbohydrates with inadequate effective fiber. Rapid fermentation produces excessive volatile fatty acids (VFAs) and lactic acid, causing ruminal pH to drop below 5.6. This acidic environment leads to chemical rumenitis, characterized by parakeratosis, erosion, and ulceration of the ruminal epithelium.

Step 2: Bacterial Translocation and Liver Abscessation

Damage to the ruminal epithelium allows bacteria, particularly Fusobacterium necrophorum and Trueperella pyogenes, to colonize the papillae and enter the portal circulation. These organisms travel to the liver where they establish abscesses in the hepatic parenchyma. The incidence of liver abscesses in feedlot cattle typically ranges from 12 to 32 percent.

Step 3: Vena Caval Thrombosis

Liver abscesses adjacent to the caudal vena cava may erode into the vessel wall. Bacterial invasion of the vascular endothelium initiates septic thrombophlebitis and formation of a white thrombus within the vena cava. The thrombus is composed of clotted blood, fibrin, dead white blood cells, bacteria, and necrotic debris. Thrombi most commonly form in the hepatic portion of the caudal vena cava.

Step 4: Metastatic Pneumonia and Pulmonary Sequelae

Septic emboli break away from the thrombus and travel through the right heart to the pulmonary arterial system. These emboli lodge in pulmonary arteries where they cause: (1) embolic pneumonia with multifocal pulmonary abscess formation, (2) pulmonary arteritis weakening vessel walls, and (3) mycotic aneurysm formation. When aneurysms erode into bronchi, massive pulmonary hemorrhage results in hemoptysis, epistaxis, and often death from exsanguination.

Bacterial Pathogens

Primary Pathogen: Fusobacterium necrophorum

Fusobacterium necrophorum is a Gram-negative, non-spore-forming, obligate anaerobic bacterium that is the primary etiologic agent of liver abscesses in cattle. It is a normal inhabitant of the rumen where it metabolizes lactic acid. Two subspecies are recognized: subsp. necrophorum (biotype A) is more virulent and isolated more frequently from infections, while subsp. funduliforme (biotype B) is less virulent and usually found in mixed cultures.

Virulence Factors of F. necrophorum

Secondary Pathogens

Clinical Presentation

Clinical signs of CVCT vary depending on disease stage and may present acutely with respiratory distress or chronically with weight loss and recurrent pneumonia. The condition is almost always fatal once clinical signs develop.

Clinical Signs by Disease Phase

Pathognomonic Signs

Bilateral foamy epistaxis with concurrent respiratory signs is highly suggestive of CVCT in cattle. Death typically occurs within 7 days after the onset of hemoptysis due to massive pulmonary hemorrhage from ruptured aneurysms. The autoauscultation position (head extended, elbows abducted) may be observed in animals with severe respiratory distress.

Diagnosis

Antemortem diagnosis of CVCT is challenging and often presumptive. A definitive diagnosis in the live animal typically requires ultrasonographic visualization of the thrombus. Most cases are confirmed at necropsy.

Diagnostic Approach

Clinical Suspicion

CVCT should be suspected in cattle presenting with: chronic pneumonia unresponsive to antimicrobials, epistaxis or hemoptysis, history of high-grain diet feeding, evidence of liver disease, and characteristic clinical signs described above.

Laboratory Findings

Ultrasonographic Findings

Ultrasonography is the most valuable antemortem diagnostic tool. Key findings include:

• Caudal vena cava shape change: Normal triangular cross-section becomes ROUND or OVAL (pathognomonic)
• Dilation: CVC diameter greater than 5 cm at the 11th-12th intercostal space
• Thrombus visualization: Hyperechoic material within the vessel lumen
• Hepatic vein dilation: Prominent hepatic vasculature due to venous congestion
• Liver abscesses: Hypoechoic centers with echogenic capsules may be visible

Pathology Findings

Gross Pathology at Necropsy

Liver Lesions

• Single or multiple hepatic abscesses adjacent to caudal vena cava
• Abscess erosion into vessel wall (pathognomonic lesion)
• Passive congestion producing "nutmeg liver" appearance
• Hepatomegaly with peritoneal adhesions

Caudal Vena Cava Lesions

• Septic thrombus (white thrombus) partially or completely occluding lumen
• Thrombus most commonly in hepatic portion but may extend to subphrenic or thoracic portions
• Thickened vessel wall with evidence of thrombophlebitis

Pulmonary Lesions

• Embolic pneumonia: RANDOMLY distributed multifocal abscesses throughout ALL lung lobes
• Pulmonary arterial aneurysms: Saccular dilations of pulmonary arteries at emboli sites
• Pulmonary hemorrhage: Focally extensive or multifocal dark-red areas from ruptured aneurysms
• Aspirated blood: Feathery, lacy-appearing red areas in subpleural lobules
• Blood clots: Free blood in major airways and bronchi

Differential Diagnosis

Treatment and Prognosis

Prognosis is GRAVE to HOPELESS. Treatment is generally unrewarding due to the advanced and irreversible nature of the lesions by the time clinical signs appear. The case fatality rate approaches 100%. If CVCT is highly suspected, humane slaughter or euthanasia may be warranted.

Treatment Options (If Attempted)

Prevention and Control

Prevention focuses on controlling the underlying cause: ruminal acidosis. Since liver abscesses are the prerequisite for CVCT, preventing the acidosis-rumenitis-liver abscess complex is paramount.

Nutritional Management Strategies

• Gradual diet transition: Adapt cattle slowly to high-grain finishing diets over 2-3 weeks
• Adequate effective fiber: Maintain roughage at 10-12% of diet with adequate particle length ("scratch factor")
• Consistent feeding: Avoid daily variations in feed mixing and delivery
• Proper bunk management: Prevent feed sorting and slug feeding
• Quality forage selection: Wheat straw or corn stalks provide better scratch factor than alfalfa hay or corn silage

Antimicrobial Prevention

Tylosin phosphate is the most commonly used in-feed antimicrobial for liver abscess prevention in feedlot cattle. It reduces abscess incidence by 40-70%. Since January 2017, tylosin use in the US requires veterinary oversight through the Veterinary Feed Directive (VFD). Other approved antimicrobials include chlortetracycline and virginiamycin, though tylosin remains most effective.

Vaccination

Vaccines targeting F. necrophorum leukotoxin are commercially available but have shown variable efficacy. Leukotoxoid vaccines may reduce liver abscess severity but have not eliminated the problem. Research continues on improved vaccine approaches.